Are You Eligible for a New Therapy That Might Prevent COVID-19? Learn More On Evusheld

Evusheld is a combination of two monoclonal antibodies, tixagevimab and cilgavimab, that is used to prevent COVID-19 in people who are at high risk of severe disease. It is given as two injections, one in each buttock, and it is not a vaccine.

Who is eligible for Evusheld?

Evusheld is authorized for emergency use in the United States for people who are:

* Immunocompromised and may not mount an adequate immune response to COVID-19 vaccination

* At high risk of severe COVID-19, including people who are 65 years of age and older, people with certain medical conditions (such as cancer, diabetes, or heart disease), and people who are pregnant

Evusheld is also authorized for use in people who have had a severe allergic reaction to a COVID-19 vaccine or to any of the ingredients in the vaccine.

How effective is Evusheld?

Evusheld has been shown to be highly effective in preventing COVID-19 in people who are at high risk of severe disease. In clinical trials, Evusheld reduced the risk of symptomatic COVID-19 by 77% in people who were immunocompromised and by 83% in people who were at high risk of severe COVID-19.

What are the side effects of Evusheld?

The most common side effects of Evusheld are injection site reactions, such as pain, redness, and swelling. Other side effects that have been reported include headache, fatigue, muscle aches, and fever.

How can I get Evusheld?

Evusheld is available through your doctor or other health care provider. If you are eligible for Evusheld, your doctor will recommend that you get it as soon as possible.

Can Evusheld be given with other COVID-19 vaccines or treatments?

Yes, Evusheld can be given with other COVID-19 vaccines or treatments. However, it is important to tell your doctor if you have received any other COVID-19 vaccines or treatments before you get Evusheld.

How long does Evusheld last?

Evusheld is expected to provide protection against COVID-19 for about six months. However, it is important to note that this is an estimate, and the actual duration of protection may vary from person to person.